Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient does not have hypertension or has Stage I or II hypertension and is taking \< 3 anti-hypertension medications~* Patient is willing to discontinue all anti-hypertensive medications during study~* Patient is willing to refrain from drinking alcohol for 24 hours prior to each study visit and is willing to limit intake at other times during the study to 2 drinks per day~* Patient agrees to avoid caffeine for 24 hours prior to each study visit. At other times during study, daily caffeine intake should not exceed 4 cups of coffee (or equivalent)~* Patient will avoid strenuous physical activity during study~* Patient is a nonsmoker or has not smoked for the last 3 months~Exclusion Criteria:~* Patient has metal implants in the leg or artificial limbs~* Patient has had a lower limb amputation, malformation, alterations in leg muscles, or a history of musculoskeletal disease~* Patient has used oral contraceptive pills or hormone replacement therapy within 3 months of screening~* Patient has a history of stroke or seizures~* Patient has a history of cancer, except that which was treated at least 10 years prior to screening and shows no evidence of recurrence

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): amlodipine
- 2 (Type: PLACEBO_COMPARATOR): Placebo to amlodipine

Based on this trial design, predict the completion outcome and termination type (if applicable).